FDA Tested 16 Formula Brands. Won’t Say Which.

FDA infant formula safety testing covered 312 samples across 16 brands, but the agency declined to name a single one.

The FDA just declared infant formulas safe. It tested 312 samples from 16 brands to reach that conclusion. It won’t tell you which brands.

TLDR

  • FDA tested 312 infant formula samples across 16 unnamed brands.
  • The agency declared all tested formulas safe for consumption.
  • Brand-level transparency was absent from the published report.
  • Operators and retailers have no public data to act on.
  • FDA infant formula safety claims rest on undisclosed sourcing.

The FDA released findings on infant formula safety this month, drawing on a broad sample set. The agency tested 312 samples. Sixteen brands were included. None were identified publicly.

FDA Infant Formula Safety: What the Data Does and Doesn’t Show

The scale of the testing is notable. Three hundred twelve samples across 16 brands represents a meaningful sweep of the market. However, the report’s value to operators, retailers, and caregivers is limited without brand attribution.

Transparency is the gap here. Manufacturers who passed testing have no mechanism to communicate that to buyers. Those who may have performed poorly face no public accountability either.

The FDA’s approach contrasts with how other food safety programs handle disclosure. The Future of Food has covered how clean-label momentum is pushing suppliers toward proactive transparency. Regulators withholding brand-level data moves in the opposite direction.

What Operators and Suppliers Should Watch

For formula manufacturers, the absence of named results is a missed credentialing opportunity. Brands investing in quality controls cannot differentiate themselves through this report.

Retailers stocking infant formula carry reputational exposure. They cannot use this FDA report to validate their shelf selections. That is a structural problem.

Significant. The FDA’s own testing program could be a powerful market signal. Right now, it is not.

The infant formula category remains under elevated scrutiny following the 2022 supply crisis. Consumers and procurement teams have not forgotten. Opacity from regulators does not rebuild that trust. It stalls it.


Source: Food Safety News. https://www.foodsafetynews.com/2026/05/fda-says-infant-formulas-are-safe/

Leave a Reply

Your email address will not be published. Required fields are marked *